Sign In

Research News letters

  
Scientists discover genetic and immunologic underpinnings of some cases of severe COVID-19
Investigational COVID-19 vaccine well-tolerated and generates immune response in older adults
Experimental COVID-19 vaccine safe, generates immune response
Study in Primates Finds Acquired Immunity Prevents COVID-19 Reinfections
Genes, Blood Type Tied to Risk of Severe COVID-19
Study identifies potential approach to treat severe respiratory distress in patients with COVID-1
ACCELERATING COVID-19 THERAPEUTIC INTERVENTIONS AND VACCINES (ACTIV)
IDSA COVID-19 Antibody Testing Primer
Serological testing for SARS-CoV-2 antibodies
At NCI, A Robust and Rapid Response to the COVID-19 Pandemic
Coronavirus (COVID-19)
COVID-19 is an emerging, rapidly evolving situation.
Coronavirus (COVID-19)
There are currently no drugs licensed for the treatment or prevention of COVID-19
Support Nurses and Midwives through COVID-19 and beyond
Statement on the third meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of coronavirus disease (COVID-19)
NIH clinical trial shows Remdesivir accelerates recovery from advanced COVID-19
Coronavirus disease (COVID-19) Pandemic
Bacille Calmette-Guérin (BCG) vaccination and COVID-19
Coronavirus disease (COVID-19) advice for the public: Myth busters
Global leaders unite to ensure everyone everywhere can access new vaccines, tests and treatments for COVID-19
NIAID strategic plan details COVID-19 research priorities
The Challenge of Tracking COVID-19’s Stealthy Spread
Expert U.S. panel develops NIH treatment guidelines for COVID-19
COVID-19, MERS & SARS
Developing Therapeutics and Vaccines for Coronaviruses
NIH Clinical Trial of Remdesivir to Treat COVID-19 Begins
NIH to launch public-private partnership to speed COVID-19 vaccine and treatment options
Antiviral remdesivir prevents disease progression in monkeys with COVID-19
Investigational chimp adenovirus MERS-CoV vaccine protects monkeys
1 - 30Next
​​​